Background Transitional cell carcinoma (TCC) accounts for around 95% of bladder cancers
and is the 4th most common cancer among men and the tenth most common in women, in …

PURPOSE: To examine the overall and stage-specific age-adjusted incidence, 5-year
survival and mortality rates of bladder cancer (BCa) in the United States, between 1973 and …

PURPOSE: Bladder cancer survival is consistently lower in female and black patients than in
male and white patients. We compared trends and differences according to clinical …

OBJECTIVE: To compare the survival of women and men with transitional cell bladder
cancer. METHODS: We used the Surveillance Epidemiology and End Results database to …

Introduction We evaluated epidemiologic trends and survival for bladder cancer histologic
subtypes in California patients by comparing urothelial carcinoma of the bladder (UCB) and …

Background To explore the overall trends of incidence rate (IR), mortality and survival
outcomes of patients with urothelial bladder cancer (UBC) over the past two decades …

The Epidemiology of Bladder Cancer - Hematology/Oncology Clinics Skip to Main Content Skip
to Main Menu Advertisement Hematology/Oncology Clinics Log in Register Log in Subscribe …

Purpose: Upper tract transitional cell carcinoma (UTTCC) is a relatively rare tumor. Overall 5-
year disease specific survival is in the range of 16.5% to 95% depending on stage. In this …

Abstract Introduction and Objective: When feasible, the treatment for all-invasive bladder
cancer is radical cystectomy. The aim of the present study was to analyze the prognostic …

BACKGROUND Bladder cancer is notable for a striking heterogeneity of disease‐specific
risks. Among the approximately 75% of incident cases found to be superficial to the …